Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
CD44 Interaction with Na+-H+ Exchanger (NHE1) Creates Acidic Microenvironments Leading to Hyaluronidase-2 and Cathepsin B Activation and Breast Tumor Cell Invasion*
Lilly Y. W. Bourguignon,
Patrick A. Singleton,
Falko Diedrich,
Robert Stern¶, , and
Eli Gilad
Department of Medicine, University of California, and Endocrine Unit, Veterans Affairs Medical Center and the ¶Department of Pathology, University of California, San Francisco, California 94121
Abstract:
We have explored CD44 (a hyaluronan (HA) receptor) interactionwith a Na+-H+ exchanger (NHE1) and hyaluronidase-2 (Hyal-2)during HA-induced cellular signaling in human breast tumor cells(MDA-MB-231 cell line). Immunological analyses demonstrate thatCD44s (standard form) and two signaling molecules (NHE1 andHyal-2) are closely associated in a complex in MDA-MB-231 cells.These three proteins are also significantly enriched in cholesteroland ganglioside-containing lipid rafts, characterized as caveolinand flotillin-rich plasma membrane microdomains. The bindingof HA to CD44 activates Na+-H+ exchange activity which, in turn,promotes intracellular acidification and creates an acidic extracellularmatrix environment. This leads to Hyal-2-mediated HA catabolism,HA modification, and cysteine proteinase (cathepsin B) activationresulting in breast tumor cell invasion. In addition, we haveobserved the following: (i) HA/CD44-activated Rho kinase (ROK)mediates NHE1 phosphorylation and activity, and (ii) inhibitionof ROK or NHE1 activity (by treating cells with a ROK inhibitor,Y27632, or NHE1 blocker, S-(N-ethyl-N-isopropyl) amiloride,respectively) blocks NHE1 phosphorylation/Na+-H+ exchange activity,reduces intracellular acidification, eliminates the acidic environmentin the extracellular matrix, and suppresses breast tumor-specificbehaviors (e.g. Hyal-2-mediated HA modification, cathepsin Bactivation, and tumor cell invasion). Finally, down-regulationof CD44 or Hyal-2 expression (by treating cells with CD44 orHyal-2-specific small interfering RNAs) not only inhibits HA-mediatedCD44 signaling (e.g. ROK-mediated Na+-H+ exchanger reactionand cellular pH changes) but also impairs oncogenic events (e.g.Hyal-2 activity, hyaluronan modification, cathepsin B activation,and tumor cell invasion). Taken together, our results suggestthat CD44 interaction with a ROK-activated NHE1 (a Na+-H+ exchanger)in cholesterol/ganglioside-containing lipid rafts plays a pivotalrole in promoting intracellular/extracellular acidificationrequired for Hyal-2 and cysteine proteinase-mediated matrixdegradation and breast cancer progression.
Received for publication October 29, 2003.
Revision received April 15, 2004.
* This work was supported by United States Public Health GrantsR01 CA66163, R01 CA 78633, and P01 AR39448 from the NationalInstitutes of Health and a Veterans Affairs Merit Review grant.The costs of publication of this article were defrayed in partby the payment of page charges. This article must thereforebe hereby marked "advertisement" in accordance with 18 U.S.C.Section 1734 solely to indicate this fact.
To whom correspondence and reprint requests should be addressed: Endocrine Unit (111N), Dept. of Medicine, University of California, San Francisco, and Veterans Affairs Medical Center, 4150 Clement St., San Francisco, CA 94121. Tel.: 415-221-4810 (Ext. 3321); Fax: 415-383-1638; E-mail: lillyb{at}itsa.ucsf.edu.
The editors suggest the following Related Resources on Science sites:
KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization.
H. Yoshida, A. Nagaoka, A. Kusaka-Kikushima, M. Tobiishi, K. Kawabata, T. Sayo, S. Sakai, Y. Sugiyama, H. Enomoto, Y. Okada, et al. (2013)
PNAS
110, 5612-5617
|Abstract »|Full Text »|PDF »
Regulation of the Na+/H+ Exchanger (NHE1) in Breast Cancer Metastasis.
B. G. Abu Jawdeh, S. Khan, I. Deschenes, M. Hoshi, M. Goel, J. T. Lock, K. Shinlapawittayatorn, G. Babcock, S. Lakhe-Reddy, G. DeCaro, et al. (2011)
J. Biol. Chem.
286, 42435-42445
|Abstract »|Full Text »|PDF »
Understanding the Dual Nature of CD44 in Breast Cancer Progression.
J. M. V. Louderbough and J. A. Schroeder (2011)
Mol. Cancer Res.
9, 1573-1586
|Abstract »|Full Text »|PDF »
Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway.
M. A. O. Magalhaes, D. R. Larson, C. C. Mader, J. J. Bravo-Cordero, H. Gil-Henn, M. Oser, X. Chen, A. J. Koleske, and J. Condeelis (2011)
J. Cell Biol.
195, 903-920
|Abstract »|Full Text »|PDF »
T. Murai, Y. Maruyama, K. Mio, H. Nishiyama, M. Suga, and C. Sato (2011)
J. Biol. Chem.
286, 1999-2007
|Abstract »|Full Text »|PDF »
V3 Versican Isoform Alters the Behavior of Human Melanoma Cells by Interfering with CD44/ErbB-dependent Signaling.
D. Hernandez, L. Miquel-Serra, M.-J. Docampo, A. Marco-Ramell, J. Cabrera, A. Fabra, and A. Bassols (2011)
J. Biol. Chem.
286, 1475-1485
|Abstract »|Full Text »|PDF »
Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion.
L. Y. W. Bourguignon, G. Wong, C. Earle, K. Krueger, and C. C. Spevak (2010)
J. Biol. Chem.
285, 36721-36735
|Abstract »|Full Text »|PDF »
High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness.
P. A. Singleton, T. Mirzapoiazova, Y. Guo, S. Sammani, N. Mambetsariev, F. E. Lennon, L. Moreno-Vinasco, and J. G. N. Garcia (2010)
Am J Physiol Lung Cell Mol Physiol
299, L639-L651
|Abstract »|Full Text »|PDF »
NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space.
G. Busco, R. A. Cardone, M. R. Greco, A. Bellizzi, M. Colella, E. Antelmi, M. T. Mancini, M. E. Dell'Aquila, V. Casavola, A. Paradiso, et al. (2010)
FASEB J
24, 3903-3915
|Abstract »|Full Text »|PDF »
Reactive Oxygen Species and Hyaluronidase 2 Regulate Airway Epithelial Hyaluronan Fragmentation.
M. E. Monzon, N. Fregien, N. Schmid, N. S. Falcon, M. Campos, S. M. Casalino-Matsuda, and R. M. Forteza (2010)
J. Biol. Chem.
285, 26126-26134
|Abstract »|Full Text »|PDF »
HGF-induced invasion by prostate tumor cells requires anterograde lysosome trafficking and activity of Na+-H+ exchangers.
J. J. Steffan, B. C. Williams, T. Welbourne, and J. A. Cardelli (2010)
J. Cell Sci.
123, 1151-1159
|Abstract »|Full Text »|PDF »
E. Takahashi, O. Nagano, T. Ishimoto, T. Yae, Y. Suzuki, T. Shinoda, S. Nakamura, S. Niwa, S. Ikeda, H. Koga, et al. (2010)
J. Biol. Chem.
285, 4060-4073
|Abstract »|Full Text »|PDF »
Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.
Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.
M. G. Slomiany, L. Dai, L. B. Tolliver, G. D. Grass, Y. Zeng, and B. P. Toole (2009)
Clin. Cancer Res.
15, 7593-7601
|Abstract »|Full Text »|PDF »
Two Novel Functions of Hyaluronidase-2 (Hyal2) Are Formation of the Glycocalyx and Control of CD44-ERM Interactions.
C. Duterme, J. Mertens-Strijthagen, M. Tammi, and B. Flamion (2009)
J. Biol. Chem.
284, 33495-33508
|Abstract »|Full Text »|PDF »
Repression of NHE1 Expression by PPAR{gamma} Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo.
A. P. Kumar, A. L. Quake, M. K. X. Chang, T. Zhou, K. S. Y. Lim, R. Singh, R. E. Hewitt, M. Salto-Tellez, S. Pervaiz, and M.-V. Clement (2009)
Cancer Res.
69, 8636-8644
|Abstract »|Full Text »|PDF »
Hyaluronan-CD44 Interaction with Protein Kinase C{epsilon} Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells.
L. Y. W. Bourguignon, C. C. Spevak, G. Wong, W. Xia, and E. Gilad (2009)
J. Biol. Chem.
284, 26533-26546
|Abstract »|Full Text »|PDF »
Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides.
M. G. Slomiany, L. Dai, P. A. Bomar, T. J. Knackstedt, D. A. Kranc, L. Tolliver, B. L. Maria, and B. P. Toole (2009)
Cancer Res.
69, 4992-4998
|Abstract »|Full Text »|PDF »
Proton Transport Inhibitors as Potentially Selective Anticancer Drugs.
S. HARGUINDEY, J. L. ARRANZ, M. L. WAHL, G. ORIVE, and S. J. RESHKIN (2009)
Anticancer Res
29, 2127-2136
|Abstract »|Full Text »|PDF »
NLRP3/Cryopyrin Is Necessary for Interleukin-1{beta} (IL-1{beta}) Release in Response to Hyaluronan, an Endogenous Trigger of Inflammation in Response to Injury.
K. Yamasaki, J. Muto, K. R. Taylor, A. L. Cogen, D. Audish, J. Bertin, E. P. Grant, A. J. Coyle, A. Misaghi, H. M. Hoffman, et al. (2009)
J. Biol. Chem.
284, 12762-12771
|Abstract »|Full Text »|PDF »
Mislocalized Scaffolding by the Na-H Exchanger NHE1 Dominantly Inhibits Fibronectin Production and TGF-{beta} Activation.
A. Karydis, M. Jimenez-Vidal, S. P. Denker, and D. L. Barber (2009)
Mol. Biol. Cell
20, 2327-2336
|Abstract »|Full Text »|PDF »
Voltage-gated Sodium Channel Activity Promotes Cysteine Cathepsin-dependent Invasiveness and Colony Growth of Human Cancer Cells.
L. Gillet, S. Roger, P. Besson, F. Lecaille, J. Gore, P. Bougnoux, G. Lalmanach, and J.-Y. Le Guennec (2009)
J. Biol. Chem.
284, 8680-8691
|Abstract »|Full Text »|PDF »
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases.
I. F. Robey, B. K. Baggett, N. D. Kirkpatrick, D. J. Roe, J. Dosescu, B. F. Sloane, A. I. Hashim, D. L. Morse, N. Raghunand, R. A. Gatenby, et al. (2009)
Cancer Res.
69, 2260-2268
|Abstract »|Full Text »|PDF »
Interaction of monocarboxylate transporter 4 with {beta}1-integrin and its role in cell migration.
S. M. Gallagher, J. J. Castorino, and N. J. Philp (2009)
Am J Physiol Cell Physiol
296, C414-C421
|Abstract »|Full Text »|PDF »
Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells.
M. G. Slomiany, G. D. Grass, A. D. Robertson, X. Y. Yang, B. L. Maria, C. Beeson, and B. P. Toole (2009)
Cancer Res.
69, 1293-1301
|Abstract »|Full Text »|PDF »
CD44 is of Functional Importance for Colorectal Cancer Stem Cells.
L. Du, H. Wang, L. He, J. Zhang, B. Ni, X. Wang, H. Jin, N. Cahuzac, M. Mehrpour, Y. Lu, et al. (2008)
Clin. Cancer Res.
14, 6751-6760
|Abstract »|Full Text »|PDF »
Chondroitin Sulfate E Fragments Enhance CD44 Cleavage and CD44-Dependent Motility in Tumor Cells.
K. N. Sugahara, T. Hirata, T. Tanaka, S. Ogino, M. Takeda, H. Terasawa, I. Shimada, J.-i. Tamura, G. B. ten Dam, T. H. van Kuppevelt, et al. (2008)
Cancer Res.
68, 7191-7199
|Abstract »|Full Text »|PDF »
Regulation of cell survival by Na+/H+ exchanger-1.
J. R. Schelling and B. G. Abu Jawdeh (2008)
Am J Physiol Renal Physiol
295, F625-F632
|Abstract »|Full Text »|PDF »
A mouse model of human mucopolysaccharidosis IX exhibits osteoarthritis.
D. C. Martin, V. Atmuri, R. J. Hemming, J. Farley, J. S. Mort, S. Byers, S. Hombach-Klonisch, R. Stern, and B. L. Triggs-Raine (2008)
Hum. Mol. Genet.
17, 1904-1915
|Abstract »|Full Text »|PDF »
Causes and Consequences of Increased Glucose Metabolism of Cancers.
R. J. Gillies, I. Robey, and R. A. Gatenby (2008)
J. Nucl. Med.
49, 24S-42S
|Abstract »|Full Text »|PDF »
Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose overexpression increases hyaluronidase 1 activity in cultured cells.
R. Hemming, D. C. Martin, E. Slominski, J. I. Nagy, A. J. Halayko, S. Pind, and B. Triggs-Raine (2008)
Glycobiology
18, 280-289
|Abstract »|Full Text »|PDF »
JAK kinases promote invasiveness in VHL-mediated renal cell carcinoma by a suppressor of cytokine signaling-regulated, HIF-independent mechanism.
K. L. Wu, H. Miao, and S. Khan (2007)
Am J Physiol Renal Physiol
293, F1836-F1846
|Abstract »|Full Text »|PDF »
CD44 Regulates Hepatocyte Growth Factor-mediated Vascular Integrity: ROLE OF c-Met, Tiam1/Rac1, DYNAMIN 2, AND CORTACTIN.
P. A. Singleton, R. Salgia, L. Moreno-Vinasco, J. Moitra, S. Sammani, T. Mirzapoiazova, and J. G. N. Garcia (2007)
J. Biol. Chem.
282, 30643-30657
|Abstract »|Full Text »|PDF »
Inducible Hyaluronan Production Reveals Differential Effects on Prostate Tumor Cell Growth and Tumor Angiogenesis.
A. G. Bharadwaj, K. Rector, and M. A. Simpson (2007)
J. Biol. Chem.
282, 20561-20572
|Abstract »|Full Text »|PDF »
Heregulin-mediated ErbB2-ERK Signaling Activates Hyaluronan Synthases Leading to CD44-dependent Ovarian Tumor Cell Growth and Migration.
L. Y. W. Bourguignon, E. Gilad, and K. Peyrollier (2007)
J. Biol. Chem.
282, 19426-19441
|Abstract »|Full Text »|PDF »
Ability of Hyaluronidase 2 To Degrade Extracellular Hyaluronan Is Not Required for Its Function as a Receptor for Jaagsiekte Sheep Retrovirus.
V. Vigdorovich, A. D. Miller, and R. K. Strong (2007)
J. Virol.
81, 3124-3129
|Abstract »|Full Text »|PDF »
CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2.
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism.
D. Sarnataro, S. Pisanti, A. Santoro, P. Gazzerro, A. M. Malfitano, C. Laezza, and M. Bifulco (2006)
Mol. Pharmacol.
70, 1298-1306
|Abstract »|Full Text »|PDF »
Tumor Cells Enhance Their Own CD44 Cleavage and Motility by Generating Hyaluronan Fragments.
K. N. Sugahara, T. Hirata, H. Hayasaka, R. Stern, T. Murai, and M. Miyasaka (2006)
J. Biol. Chem.
281, 5861-5868
|Abstract »|Full Text »|PDF »
Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding.
G. Tzircotis, R. F. Thorne, and C. M. Isacke (2005)
J. Cell Sci.
118, 5119-5128
|Abstract »|Full Text »|PDF »
Characterization of Promoter Elements of the Human HYAL-2 Gene.
Antisense-Mediated Suppression of Hyaluronan Synthase 2 Inhibits the Tumorigenesis and Progression of Breast Cancer.
L. Udabage, G. R. Brownlee, M. Waltham, T. Blick, E. C. Walker, P. Heldin, S. K. Nilsson, E. W. Thompson, and T. J. Brown (2005)
Cancer Res.
65, 6139-6150
|Abstract »|Full Text »|PDF »
Protein Kinase A Gating of a Pseudopodial-located RhoA/ROCK/p38/NHE1 Signal Module Regulates Invasion in Breast Cancer Cell Lines.
R. A. Cardone, A. Bagorda, A. Bellizzi, G. Busco, L. Guerra, A. Paradiso, V. Casavola, M. Zaccolo, and S. J. Reshkin (2005)
Mol. Biol. Cell
16, 3117-3127
|Abstract »|Full Text »|PDF »
Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2.
S. Misra, S. Ghatak, and B. P. Toole (2005)
J. Biol. Chem.
280, 20310-20315
|Abstract »|Full Text »|PDF »
Hyaluronan-CD44 Interaction with IQGAP1 Promotes Cdc42 and ERK Signaling, Leading to Actin Binding, Elk-1/Estrogen Receptor Transcriptional Activation, and Ovarian Cancer Progression.
L. Y. W. Bourguignon, E. Gilad, K. Rothman, and K. Peyrollier (2005)
J. Biol. Chem.
280, 11961-11972
|Abstract »|Full Text »|PDF »
Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells.